Medicine
VOXZOGO 0.4mg kit
VOXZOGO 0.4mg kit is a prescription medicine containing Vosoritide, marketed by BioMarin Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in the original package to protect from light.
Key facts
- Active ingredient (INN)
- Vosoritide
- Brand
- VOXZOGO 0.4mg
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- BioMarin Pharmaceutical
- Manufacturer
- BioMarin Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Store in the original package to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M05BX Bone disease treatments, subgroup M05B, subgroup M05BX
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 November 2021
- Identifiers
- RxCUI 2586364, 2586369, 2586371 +3DailyMed set ID 228e8560-04a4-4bb1-a81f-29531a9e4d27NDC 68135-082Application NDA214938
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 10 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose * 10 injection, solution in 1 carton | 68135-082-36 | BioMarin Pharmaceutical | 19 November 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Vosoritide kit.
Clinical summary
Vosoritide is a prescription medicine indicated to increase linear growth in pediatric patients with achondroplasia with open epiphyses. It is available as kits. MedsAcross supplies Vosoritide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VosoritideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VOXZOGO 0.4mg prescribing information (BioMarin Pharmaceutical) · U.S. National Library of Medicine, DailyMed
- Voxzogo: European public assessment report (EPAR) · European Medicines Agency
Need VOXZOGO 0.4mg kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.